Literature DB >> 809280

Purification of alpha1-antitrypsin from plasma through thiol-disulfide interchange.

C B Laurell, J Pierce, U Persson, E Thulin.   

Abstract

1. Monomeric nu-chains were conjugated with CNBr-activated Sepharose 4B. The C-terminal cysteine of the conjugated nu-chain was converted to a mixed disulfide with 3-carboxy-4-nitro-benzenethiol (Nbs) and used to separate plasma proteins with reactive thiol groups. The plasma proteins, alpha1-antitrypsin and prealbumin have the greatest affinity for the interchange reaction with mixed disulfides. The disulfide link between alpha1-antitrypsin and nu-chain is sensitive to excess Nbs, and is selectively cleaved in the presence of 5,5'-dithiobis(2-nitrobenzoate) (Nbs2) which accepts the sulfhydryl group of alpha1-antitrypsin. 2. A Simple method developed for the isolation of human alpha1-antitrypsin was equally effective for the various inherited phenotypes and for alpha1-antitrypsin from the dog, baboon, and monkey, Glutathione-Sepharose was also used successfully, but the nu-chain conjugate yielded alpha1-antitrypsin less contaminated with mercaptalbumin and prealbumin. 3. The alpha1-antitrypsin is harvested from this procedure as a mixed disulfide with Nbs. The negative charge of Nbs at pH 8.1 causes an increased electrophoretic mobility of the alpha1-antitrypsin derivative. Mild reduction liberates Nbs and electrophoretic mobility of alpha1-antitrypsin returns to normal. The method described can increase the alpha1-antitrypsin content of a plasma fraction from 5% of the total protein to 95% within one day with a yield of about 50%. This purification procedure does not exert any detectable effect on microheterogeneity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809280     DOI: 10.1111/j.1432-1033.1975.tb02281.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.

Authors:  M C Vissers; P M George; I C Bathurst; S O Brennan; C C Winterbourn
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

2.  Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin.

Authors:  H L James; A B Cohen
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

3.  The role of elastases in the development of emphysema.

Authors:  Charles Kuhn; Robert M Senior
Journal:  Lung       Date:  1978-12       Impact factor: 2.584

4.  Human neutrophil collagenase cleaves alpha 1-antitrypsin.

Authors:  J Michaelis; M C Vissers; C C Winterbourn
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

5.  High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice.

Authors:  A L Archibald; M McClenaghan; V Hornsey; J P Simons; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Approaches to maximizing stable expression of alpha 1-antitrypsin in transformed CHO cells.

Authors:  T Paterson; J Innes; S Moore
Journal:  Appl Microbiol Biotechnol       Date:  1994-01       Impact factor: 4.813

7.  Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.

Authors:  K F Smith; R A Harrison; S J Perkins
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

8.  Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.

Authors:  F Ogushi; G A Fells; R C Hubbard; S D Straus; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  Rabbit monoarticular arthritis as a model for intra-articular drug injections. The local action of administered cortisol and alpha-1 proteinase inhibitor.

Authors:  E Pitt; D A Lewis
Journal:  Agents Actions       Date:  1984-12

10.  Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.

Authors:  F Ogushi; R C Hubbard; C Vogelmeier; G A Fells; R G Crystal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.